Scientists Clone SARS-CoV-2 Genome with Quick Yeast-Based Method

The use of yeast artificial chromosomes has enabled the rapid genetic reconstruction of the novel coronavirus.

Written byRuth Williams
| 4 min read
Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Researchers have generated a full-length clone of the novel coronavirus genome using artificial chromosomes in brewers’ yeast, according to a paper published in Nature on Monday (May 4). While other laboratories are constructing, or have constructed, clones of SARS-CoV-2 by alternative methods, a major benefit of the yeast system is its speed and stability, researchers say.

“The exciting thing about the yeast is that . . . it’s fast,” says microbiologist and coronavirus expert Susan Weiss of the University of Pennsylvania Perelman School of Medicine who was not a member of the research team. “The other methods are tedious and difficult.”

Reconstructing and modifying the genomes of disease-causing viruses is the starting point of many research endeavors in virology. These genetic manipulations are essential for studying a virus’s method of infection, its replication, drugs that might work against it, and potential vaccines.

During outbreaks and pandemics of novel viruses, “speed ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • ruth williams

    Ruth is a freelance journalist. Before freelancing, Ruth was a news editor for the Journal of Cell Biology in New York and an assistant editor for Nature Reviews Neuroscience in London. Prior to that, she was a bona fide pipette-wielding, test tube–shaking, lab coat–shirking research scientist. She has a PhD in genetics from King’s College London, and was a postdoc in stem cell biology at Imperial College London. Today she lives and writes in Connecticut.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies